The U.S. Food and Drug Administration recently approved Xiaflex (collagenase clostridium histolyticum) as the first drug to treat a progressive hand disease known as Dupuytren's contracture, which can affect a person's ability to straighten and properly use their fingers. (Source: Pharmaceutical Online News)
Read More... [Source: MedWorm: Dupuytren's Contracture - Posted by FreeAutoBlogger]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment